Changeflow GovPing Healthcare & Life Sciences Method for Preparing Biotic Superparamagnetic N...
Priority review Consultation Added Proposed

Method for Preparing Biotic Superparamagnetic Nanoparticles Derived from Colchicum Ritchii

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

USPTO has published patent application US20260108578A1 for a method of preparing biotic superparamagnetic nanoparticles using Colchicum ritchii plant extract. The application, filed on January 17, 2025 by inventors Veeramoni Chinnadurai, Khalid A. Al-Numair, and Mohammed A. Alsaif, describes combining the plant extract with ferric chloride solution followed by sodium hydroxide to form superparamagnetic nanoparticles. The invention is classified under CPC codes A61K 36/88, A61K 9/5115, A61K 9/5192, A61K 47/02, A61P 3/04, and A61P 3/10, indicating applications in pharmaceutical preparations for metabolic disorders.

“A method of preparing biotic super-paramagnetic nanoparticles can include combining a Colchicum ritchii plant extract with a ferric chloride solution to provide a mixture and adding sodium hydroxide solution to the mixture to provide the super-paramagnetic nanoparticles.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

USPTO classification A61K covers pharmaceutical preparations: formulations, dosage forms, combination therapies, delivery systems, and the vehicles that carry active ingredients. Every newly published application in A61K lands in this feed, around 245 a month. Applications publish 18 months after filing, so this feed reveals what pharma formulators at major sponsors and generics were working on in the prior year and a half. Watch this if you compete in drug formulation, file freedom-to-operate analyses, scout competitive drug products before clinical readouts, or follow novel delivery platforms like nanoparticles, lipid carriers, and long-acting injectables.

What changed

USPTO has published patent application US20260108578A1, a new pharmaceutical method for synthesizing biotic superparamagnetic nanoparticles derived from Colchicum ritchii plant material. The method involves combining the plant extract with ferric chloride solution and subsequently adding sodium hydroxide to produce the nanoparticles.

Pharmaceutical and biotechnology companies researching nanoparticle synthesis, drug delivery systems, or metabolic disorder treatments should monitor this application. Competitors developing similar biotic magnetic nanoparticle platforms may wish to conduct freedom-to-operate analyses. Research institutions may find this document relevant for prior art searches in the pharmaceutical preparation space.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHOD FOR PREPARING BIOTIC SUPERPARAMAGNETIC NANOPARTICLES DERIVED FROM COLCHICUM RITCHII

Application US20260108578A1 Kind: A1 Apr 23, 2026

Inventors

VEERAMANI CHINNADURAI, KHALID A. AL-NUMAIR, MOHAMMED A. ALSAIF

Abstract

A method of preparing biotic super-paramagnetic nanoparticles can include combining a Colchicum ritchii plant extract with a ferric chloride solution to provide a mixture and adding sodium hydroxide solution to the mixture to provide the super-paramagnetic nanoparticles.

CPC Classifications

A61K 36/88 A61K 9/5115 A61K 9/5192 A61K 47/02 A61P 3/04 A61P 3/10

Filing Date

2025-01-17

Application No.

19027850

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Consultation
Branch
Executive
Legal weight
Non-binding
Stage
Proposed
Change scope
Substantive

Who this affects

Applies to
Pharmaceutical companies Manufacturers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application Pharmaceutical research Nanoparticle synthesis
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!